High Dose Atropine Curbs Myopia in Kids Despite Side Effects
TOPLINE:According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more efficient in managing myopia development and axial elongation than placebo eye drops in kids regardless of triggering blurred vision and photophobia in some individuals.METHOD:Scientist carried out a secondary analysis of the 3-year outcomes of the MOSAIC trial to examine the effectiveness and security of various atropine routines in treatment-naive kids aged 6-16 years with a round comparable ≤ − 0.50 diopters (D).They evaluated information of 199 kids in Europe with myopia (mean age, 13.9 years; 60.8% women) who were arbitrarily appointed to either group 1 (nighttime placebo for 2 years followed by 0.05% atropine eye drops for 1 year;...